Shares News

Intel stock forecast: What’s next for INTC after poor earnings?
Discover the Intel (INTC) share price forecast for 2025 and beyond, with analyst price targets and more
18:17, 8 September 2025

Druckenmiller just sold all his Palantir shares
f you had invested $10,000 in Palantir just three years ago, that investment would be worth over $150,000 today. That's a staggering 1,500% return. That same $10,000 invested in Nvidia, the largest company in the world, would have turned into $81,000.
15:45, 5 September 2025

Tesla stock forecast: Third-party TSLA price target
Discover the Tesla (TSLA) share price forecast for 2025 and beyond, with third-party analysts’ price targets and more.
14:41, 5 September 2025

Bill Ackman's biggest trade ever
If you invested $10,000 in Uber exactly three years ago, it would be worth over $30,000 today. That’s more than a 300% return and nearly five times the S&P 500’s performance over the same period.
13:43, 5 September 2025

US 500 index forecast: Third-party US 500 price target
Discover the US 500 (US 500) index price forecast for 2025 and beyond, with analyst price targets and more.
12:59, 5 September 2025

MicroStrategy stock forecast: Third-party MSTR price target
Discover the MicroStrategy (MSTR) share price forecast for 2025 and beyond, with analyst price targets and more.
09:48, 5 September 2025

MongoDB stock forecast 2025-2050: Third-party MDB price target
Discover the MongoDB (MDB) share price forecast for 2025 and beyond, with analyst price targets and more
08:48, 5 September 2025

US Wall Street 30 index forecast: Is US30 a Good Investment?
Discover the US Wall Street 30 (Dow Jones Industrial Average) index price forecast for 2025 and beyond, with analyst price targets and more
13:08, 3 September 2025

Coinbase stock forecast: Third-party COIN price target
Discover the Coinbase (COIN) share price outlook for 2025 and beyond, with analyst targets and more.
10:50, 3 September 2025

GlaxoSmithKline stock forecast 2025-2050: Third-party GSK price target
GlaxoSmithKline (GSK) is a leading British multinational pharmaceutical and biotechnology company, focused on vaccines, and specialty medicines.
15:30, 28 August 2025